We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
The global synthetic biology and biomanufacturing market is poised for exceptional growth by 2036, driven by the adoption of sustainable bio-based production methods across industries. Key ...
At the 2026 JP Morgan Healthcare Conference, CytoReason unveiled LINA, an AI agent designed to support pharmaceutical research and development.
Tahoe, Arc, and Biohub have played leading roles in advancing virtual cell models: AI systems capable of simulating cellular ...
News-Medical.Net on MSN
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.
If penicillin was discovered on moldy bread, who's to say the next miracle drug won't be born from AI hallucinations ...
We know the genes, but not their functions.” To resolve this long-standing bottleneck in microbial research, a joint research team has proposed a ...
Cambridge-based genomics and drug discovery fledgling OutSee has closed its £2.5 million seed round and signed a strategic ...
Healthcare organizations gain access to Claude Opus 4.5’s reasoning capabilities specifically optimized for medical and ...
Practicing physician and health system AI leader brings frontline and enterprise perspective to Brim Analytics' ...
D organoids, derived from stem cells or patient tissues, faithfully replicate the architecture and functions specific to various organs with remarkable ...
La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback